JOURNAL OF TOXICOLOGICAL SCIENCES

根据COPE关于作者身份与AI工具的立场声明，作者必须在“材料与方法”部分披露并完整描述任何生成式或非生成式人工智能（AI）工具（也称大语言模型，LLM）的使用，包括但不限于用AI收集或分析数据、制作或修改稿件中的图像或图形，或撰写全部或部分稿件；作者须说明使用了哪些工具以及如何使用。 模型中文摘要

As per the COPE position statement on Authorship and AI tools, authors must disclose and fully describe any use of generative or non-generative artificial intelligence (AI) tools (also known as large language models, or LLMs) in the Materials and Methods section. This includes, but is not limited to, using AI tools to collect or analyze data, produce or amend images or graphics used in the manuscr…

作者必须提供遵循CRediT（贡献者角色分类）的作者贡献声明，用14个CRediT类别中的一个或多个描述每位作者的贡献。 模型中文摘要

Authors are required to include an Author Contribution Statement that follows CRediT (Contributor Roles Taxonomy). Each author’s contribution should be described using one or more of the 14 CRediT categories. For example (where ‘Author’ is replaced by the actual author names): Conceptualization: Author 1. Funding acquisition: Author 1. Investigation: Author 1, Author 2. Supervision: Author 1. Visu…

作者必须声明与所述工作相关的任何竞争性财务或其他利益冲突；如无声明利益，作者应在稿件该部分加入“作者声明无竞争利益”的表述。 模型中文摘要

Authors are required to declare any competing financial or other conflicts of interest in relation to the work described. Please see the ‘Author competing interests and conflicts of interest’ section for detailed information. If there are no declared interests, authors should include the following statement in this section of their manuscript: “The authors declare no competing interests.”

对于报告研究数据结果的稿件，鼓励作者提供数据可用性声明，说明稿件数据可在何处获取并（如适用）直接链接到数据；若研究数据未公开，应在此说明并注明获取数据的条件。 模型中文摘要

Authors are encouraged to include a Data Availability Statement in manuscripts that report results from research data. Following Hrynaszkiewicz et al. (2020, http://doi.org/10.5334/dsj-2020-017), statements should include information on where the manuscript’s data can be found and (where applicable) directly link to the data. If research data are not publicly available, this should be stated in th…

作者必须声明，对涉及人类或动物受试者的任何研究均已获得并遵守相关伦理批准。 模型中文摘要

Authors are required to declare that they have obtained and complied with relevant ethics approvals for any studies involving human or animal subjects.

自2025年6月1日起，期刊更新版权政策并引入开放知识共享许可；自该日期起投稿的稿件，作者保留版权并向日本毒理学会提供知识共享许可（CC BY 4.0，署名4.0国际），该许可允许在注明出处的情况下共享和改编文章（包括商业用途）；2025年6月1日之前投稿文章的版权归学会所有。 模型中文摘要

Copyright and licensing On June 1, 2025 the journal will update its copyright policies and introduce open Creative Commons licensing. For manuscripts submitted from this date, authors retain copyright in their work and provide the Japanese Society of Toxicology a License to Publish their article under a Creative Commons license: CC BY 4.0 (Attribution 4.0 International). This license allows users …

对于以CC BY 4.0许可发表的论文，作者（或他人）可在期刊发表后立即将任何或所有版本的稿件上传至机构存储库，只要遵守许可条件及本文档其他版权要求，并须在存储库文章页面加入指向文章DOI的链接。 模型中文摘要

Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. For works published in the journal under a CC BY 4.0 license, authors (or others) can upload any or all versions of a manuscript to an institutional repository immediately after publication in the journal, as long as the conditions of the license, and other copyright requ…

期刊采用双盲同行评审；稿件提交后由主编进行初筛，不符合期刊范围或不适合发表的稿件直接拒稿，其余稿件由主编分配给副主编负责同行评审，副主编遴选两名或以上合适的审稿人，审稿人报告提交期限为两周。 模型中文摘要

Editorial and peer review process The journal uses double anonymized peer review. When a manuscript is submitted to the journal, it is assigned to the Editor-in-Chief, who performs initial screening. Manuscripts that do not fit the journal’s scope or are not deemed suitable for publication are rejected without review. The Editor-in-Chief allocates each of the remaining manuscripts to an Associate …

期刊鼓励作者在投稿前或与投稿同时将研究稿件发布在社区认可的预印本服务器上；该政策仅适用于描述原始研究的稿件原始版本，经审稿意见修改、被接受或已发表的版本不应发布在预印本服务器，可在预印本服务器发布指向已发表稿件的链接。 模型中文摘要

To support the wide dissemination of research, the journal encourages authors to post their research manuscripts on community-recognized preprint servers, either before or alongside submission to the journal. This policy applies only to the original version of a manuscript that describes primary research. Any version of a manuscript that has been revised in response to reviewers’ comments, accepte…

自存档（绿色开放获取）允许作者将稿件副本存入在线存储库；对于以CC BY 4.0许可发表的论文，作者（或他人）可在期刊发表后立即将任何或所有版本的稿件上传至机构存储库，只要遵守许可条件及其他版权要求，并须在存储库文章页面加入指向文章DOI的链接。 模型中文摘要

Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. For works published in the journal under a CC BY 4.0 license, authors (or others) can upload any or all versions of a manuscript to an institutional repository immediately after publication in the journal, as long as the conditions of the license, and other copyright requ…

期刊遵循ICMJE临床试验注册政策，建议所有临床试验在首例受试者入组时或之前在公开试验注册库注册，作为考虑发表的条件；描述临床试验的稿件必须包含试验注册号和试验注册库名称。 模型中文摘要

The journal adheres to the ICMJE policy on Clinical Trials Registration, which recommends that all clinical trials are registered in a public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. Manuscripts describing clinical trials must include the registration number of the trial and the name of the trial registry.